OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of dendritic cells in cancer and anti-tumor immunity
Ariel E. Marciscano, Niroshana Anandasabapathy
Seminars in Immunology (2021) Vol. 52, pp. 101481-101481
Open Access | Times Cited: 170
Ariel E. Marciscano, Niroshana Anandasabapathy
Seminars in Immunology (2021) Vol. 52, pp. 101481-101481
Open Access | Times Cited: 170
Showing 1-25 of 170 citing articles:
Dendritic cell subsets in cancer immunity and tumor antigen sensing
Annalisa Del Prete, Valentina Salvi, Alessandra Soriani, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 5, pp. 432-447
Open Access | Times Cited: 271
Annalisa Del Prete, Valentina Salvi, Alessandra Soriani, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 5, pp. 432-447
Open Access | Times Cited: 271
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 104
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 104
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
Targeting innate immune pathways for cancer immunotherapy
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 78
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 78
Augmenting Immunotherapy via Bioinspired MOF‐Based ROS Homeostasis Disruptor with Nanozyme‐Cascade Reaction
Ruifang Wang, Maosong Qiu, Lei Zhang, et al.
Advanced Materials (2023) Vol. 35, Iss. 49
Closed Access | Times Cited: 63
Ruifang Wang, Maosong Qiu, Lei Zhang, et al.
Advanced Materials (2023) Vol. 35, Iss. 49
Closed Access | Times Cited: 63
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy
Xueqiang Peng, Jianjun Fang, Chuyuan Lou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3432-3456
Open Access | Times Cited: 23
Xueqiang Peng, Jianjun Fang, Chuyuan Lou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3432-3456
Open Access | Times Cited: 23
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
Ana Santiso, Ákos Heinemann, Julia Kargl
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 388-413
Open Access | Times Cited: 16
Ana Santiso, Ákos Heinemann, Julia Kargl
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 388-413
Open Access | Times Cited: 16
A new era of cancer immunotherapy: vaccines and miRNAs
Gitika Sareen, Maneesh Mohan, Ashi Mannan, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access | Times Cited: 2
Gitika Sareen, Maneesh Mohan, Ashi Mannan, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access | Times Cited: 2
Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness
Robby Barnestein, Loïck Galland, Laura Kalfeist, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 57
Robby Barnestein, Loïck Galland, Laura Kalfeist, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 57
Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing
Wei Li, Binglei Zhang, Weijie Cao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Wei Li, Binglei Zhang, Weijie Cao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 32
JunB: a paradigm for Jun family in immune response and cancer
Fujia Ren, Xiaoyu Cai, Yao Yao, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 28
Fujia Ren, Xiaoyu Cai, Yao Yao, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 28
Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy
Rui Wang, Wenqin Song, Jie Zhu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 84-96
Closed Access | Times Cited: 14
Rui Wang, Wenqin Song, Jie Zhu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 84-96
Closed Access | Times Cited: 14
Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy
Dinh Chuong Nguyen, Kefan Song, Simbarashe Jokonya, et al.
ACS Central Science (2024) Vol. 10, Iss. 3, pp. 666-675
Open Access | Times Cited: 14
Dinh Chuong Nguyen, Kefan Song, Simbarashe Jokonya, et al.
ACS Central Science (2024) Vol. 10, Iss. 3, pp. 666-675
Open Access | Times Cited: 14
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 14
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 14
Dendritic Cells in Shaping Anti-Tumor T Cell Response
Luciano Mazzoccoli, Bei Liu
Cancers (2024) Vol. 16, Iss. 12, pp. 2211-2211
Open Access | Times Cited: 14
Luciano Mazzoccoli, Bei Liu
Cancers (2024) Vol. 16, Iss. 12, pp. 2211-2211
Open Access | Times Cited: 14
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases
Camille Rolin, Jacques Zimmer, Carole Seguin‐Devaux
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 7, pp. 643-661
Open Access | Times Cited: 12
Camille Rolin, Jacques Zimmer, Carole Seguin‐Devaux
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 7, pp. 643-661
Open Access | Times Cited: 12
The role of dendritic cells in cancer immunity and therapeutic strategies
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 11
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 11
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy
Jie Chen, Yu-Hang Duan, Junye Che, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1047-1070
Open Access | Times Cited: 10
Jie Chen, Yu-Hang Duan, Junye Che, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1047-1070
Open Access | Times Cited: 10
Unraveling the tumor microenvironment of esophageal squamous cell carcinoma through single-cell sequencing: A comprehensive review
Lingyu Qi, Jiaxin Wang, Shuang Hou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189264-189264
Closed Access | Times Cited: 1
Lingyu Qi, Jiaxin Wang, Shuang Hou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189264-189264
Closed Access | Times Cited: 1
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system
Rebecca Anne Bekker, Sungjune Kim, Shari Pilon‐Thomas, et al.
Neoplasia (2022) Vol. 28, pp. 100796-100796
Open Access | Times Cited: 38
Rebecca Anne Bekker, Sungjune Kim, Shari Pilon‐Thomas, et al.
Neoplasia (2022) Vol. 28, pp. 100796-100796
Open Access | Times Cited: 38
Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma
Yuyan Xu, Wei Liao, Qiong Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Yuyan Xu, Wei Liao, Qiong Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Dendritic Cell-Based Vaccines Against Cancer: Challenges, Advances and Future Opportunities
Chunmei Fu, Tianle Ma, Li Zhou, et al.
Immunological Investigations (2022) Vol. 51, Iss. 8, pp. 2133-2158
Closed Access | Times Cited: 33
Chunmei Fu, Tianle Ma, Li Zhou, et al.
Immunological Investigations (2022) Vol. 51, Iss. 8, pp. 2133-2158
Closed Access | Times Cited: 33
